Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Factor VIII × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Cyclophosphamide 30 fludarabine phosphate 27 Whole-Body Irradiation 27 Mycophenolic Acid 25 Busulfan 19 fludarabine 18 Tacrolimus 17 Cyclosporine 17 Melphalan 15 Peripheral Blood Stem Cell Transplantation 13 Filgrastim 11 Antilymphocyte Serum 11 Granulocyte Colony-Stimulating Factor 10 Cytarabine 10 Cord Blood Stem Cell Transplantation 10 Methotrexate 9 thymoglobulin 7 eltrombopag 7 Epoetin Alfa 7 Dalteparin 7 romiplostim 6 Thiotepa 6 Etoposide 6 Alemtuzumab 6 apixaban 5 Lenalidomide 5 Darbepoetin alfa 5 epoetin beta 4 emicizumab 4 Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02847637 2022-11-16

HAVEN 3

Hoffmann-La Roche

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡